A need determines the path….

Mediscience Technology Corporation is engaged in the design and development of diagnostic medical devices that detect cancer using light induced native tissue fluorescence spectroscopy (the "Technology") to distinguish between malignant and normal or benign tissue.

We have successfully conducted both preclinical and clinical evaluations which support the value of our proprietary technology, a breakthrough in the screening and diagnostics of cervical, esophageal, oral, and colon cancer.

Our technology will have substantial commercial appeal due to its non-invasive character, its delivery of immediate results, and its enhanced diagnostic sensitivity and specificity.